Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Net Income (2016 - 2025)

Historic Net Income for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to -$18.1 million.

  • Medifast's Net Income fell 237289.84% to -$18.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$18.7 million, marking a year-over-year decrease of 100591.95%. This contributed to the annual value of -$18.7 million for FY2025, which is 99468.14% down from last year.
  • Medifast's Net Income amounted to -$18.1 million in Q4 2025, which was down 237289.84% from -$2.3 million recorded in Q3 2025.
  • In the past 5 years, Medifast's Net Income ranged from a high of $47.0 million in Q2 2021 and a low of -$18.1 million during Q4 2025
  • In the last 5 years, Medifast's Net Income had a median value of $24.8 million in 2022 and averaged $19.5 million.
  • Over the last 5 years, Medifast's Net Income had its largest YoY gain of 13036.81% in 2025, and its largest YoY loss of 237289.84% in 2025.
  • Medifast's Net Income (Quarter) stood at $34.0 million in 2021, then fell by 22.06% to $26.5 million in 2022, then crashed by 77.24% to $6.0 million in 2023, then crashed by 86.79% to $797000.0 in 2024, then crashed by 2372.9% to -$18.1 million in 2025.
  • Its Net Income stands at -$18.1 million for Q4 2025, versus -$2.3 million for Q3 2025 and $2.5 million for Q2 2025.